Regulation of actively proliferating and quiescent intestinal stem cells
活跃增殖和静止肠道干细胞的调节
基本信息
- 批准号:8917929
- 负责人:
- 金额:$ 37.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-22 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:ALCAM geneAddressAdenovirusesAnemiaBackBioinformaticsCell Culture TechniquesCell divisionCellsClonalityCollaborationsColonColon CarcinomaColorectal CancerColumnar CellDataDefectDevelopmentDuodenumEpithelialExhibitsFrequenciesGRP78 geneGeneticGoalsGrowthHealthHereditary DiseaseHomeostasisHumanIn Situ HybridizationIn VitroInjuryIntestinal DiseasesIntestinesIronLabelMalignant - descriptorMediatingMethodologyMethodsModelingMolecularMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesNatural regenerationNatureOncogenicOrganoidsPathogenesisPathway interactionsPhenotypePopulationPositioning AttributeProliferatingReagentRegulationRepressionResearch Project GrantsSHFM1 geneSerumSignal TransductionSmall IntestinesSpatial DistributionStem cell transplantStem cellsTranslationsTransplantationUp-Regulationautocrinebasecancer stem cellcell behaviordisease phenotypegain of functionin vivoloss of functionmetal transporting protein 1microcytic anemiamolecular markernext generationnovelnovel markerperipheral bloodprogenitorreceptorreconstitutionregenerativestem cell biologystem cell divisionstem cell nichestem cell populationtranscriptome sequencingtumorvillin
项目摘要
DESCRIPTION (provided by applicant): The tremendous regenerative capacity of the intestine, with epithelial turnover every 5-7 days, is mediated by the carefully orchestrated activity of intestinal stem cells (ISC). The recent identification of molecular markers for ISCs, combined with in vivo lineage tracing and in vitro primary organoid culture methodologies has revolutionized ISC biology. The resultant wealth of findings have showcased ISCs as a robust general paradigm for stem cell behavior and have elicited a next generation of studies exploring the ISC niche, interrelationships and interconversion of actively cycling versus quiescent ISC populations, and translational applications of ISC transplantation. Accordingly, the current application is a continuation of our prior 5 year project for the NIDDK Intestinal Stem Cell Consortium (ISCC), and is responsive to RFA-DK-13-012, Intestinal Stem Cell Consortium Research Projects (U01), seeking to "define conditions controlling proliferation and differentiation of intestinal stem cells", "determine the developmental lineage of characterized populations of stem cells in the small intestine" and "methods for expanding and grafting stem cells back into the intestine". Here, we build upon our preliminary data from the prior cycle with novel reagents and methodologies. Aim 1 explores R-spondins as regulators of Lgr5+ ISC symmetric cell division combining adenovirus-mediated gain- and loss-of-function approaches with in vivo lineage tracing, and pursuing mechanistic and niche localization studies. In Aim 2, interrelationships between diverse cycling and quiescent ISC populations will be investigated by RNA-Seq, and novel lineage relationships of Bmi1+ ISC will be explored. Aims 3 and 4 explore translational aspects of ISC biology, with Aim 3 utilizing organoid culture to evaluating the effects of R- spondins on colon cancer stem cells, and Aim 4 attempting the phenotypic correction of a Mendelian intestinal epithelial defect by ISC transplantation. Overall, these studies describe an integrated approach to ISC biology and translation that is highly responsive to RFA-DK-13-012, Intestinal Stem Cell Consortium Research Projects (U01), with implications for stem cell biology, and intestinal disease pathogenesis and therapy.
描述(由申请人提供):肠道的巨大再生能力,每 5-7 天就有一次上皮更新,是由肠道干细胞 (ISC) 精心策划的活动介导的。最近对 ISC 分子标记的鉴定,结合体内谱系追踪和体外原代类器官培养方法,彻底改变了 ISC 生物学。由此产生的大量研究结果表明,ISC是干细胞行为的一个强大的通用范式,并引发了下一代研究,探索ISC生态位、活跃循环与静止ISC群体的相互关系和相互转换,以及ISC移植的转化应用。因此,当前的申请是我们之前 NIDDK 肠道干细胞联盟 (ISCC) 5 年项目的延续,并响应 RFA-DK-13-012、肠道干细胞联盟研究项目 (U01),寻求“定义控制肠道干细胞增殖和分化的条件”、“确定小肠干细胞特征群体的发育谱系”以及“扩增和分化的方法”将干细胞移植回肠道”。在这里,我们利用新的试剂和方法建立在前一个周期的初步数据的基础上。目标 1 探索 R-spondins 作为 Lgr5+ ISC 对称细胞分裂的调节剂,将腺病毒介导的功能获得和功能丧失方法与体内谱系追踪相结合,并进行机制和生态位定位研究。在目标 2 中,将通过 RNA-Seq 研究不同循环和静止 ISC 群体之间的相互关系,并将探索 Bmi1+ ISC 的新谱系关系。目标 3 和 4 探索 ISC 生物学的转化方面,目标 3 利用类器官培养来评估 R-spondins 对结肠癌干细胞的影响,目标 4 尝试通过 ISC 移植来纠正孟德尔肠上皮缺陷的表型。总体而言,这些研究描述了一种 ISC 生物学和翻译的综合方法,该方法对 RFA-DK-13-012、肠道干细胞联盟研究项目 (U01) 高度敏感,对干细胞生物学以及肠道疾病发病机制和治疗具有影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CALVIN J KUO其他文献
CALVIN J KUO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CALVIN J KUO', 18)}}的其他基金
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
共保存肿瘤和浸润免疫区室的类器官的免疫治疗模型
- 批准号:
10374163 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
共保存肿瘤和浸润免疫区室的类器官的免疫治疗模型
- 批准号:
10586140 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Core 2: Stanford Breast Metastasis Center Organoid Core
核心 2:斯坦福乳腺转移中心类器官核心
- 批准号:
10272393 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity
SARS-CoV-2 刺激的先天性和适应性免疫的肠道类器官模型
- 批准号:
10654752 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity
SARS-CoV-2 刺激的先天性和适应性免疫的肠道类器官模型
- 批准号:
10319858 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity
SARS-CoV-2 刺激的先天性和适应性免疫的肠道类器官模型
- 批准号:
10450851 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Core 2: Stanford Breast Metastasis Center Organoid Core
核心 2:斯坦福乳腺转移中心类器官核心
- 批准号:
10704695 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
共保存肿瘤和浸润免疫区室的类器官的免疫治疗模型
- 批准号:
10212018 - 财政年份:2021
- 资助金额:
$ 37.15万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 37.15万 - 项目类别:
Glutaredoxin, Glutathione Metabolism and Lung Cancer
谷氧还蛋白、谷胱甘肽代谢与肺癌
- 批准号:
10657945 - 财政年份:2023
- 资助金额:
$ 37.15万 - 项目类别:
Molecular mechanisms mediating the soft tissue attachment to teeth
介导软组织附着到牙齿的分子机制
- 批准号:
10838302 - 财政年份:2023
- 资助金额:
$ 37.15万 - 项目类别:
A Novel Vector Platform to Actualize T Cell Modification In Vivo
一种在体内实现 T 细胞修饰的新型载体平台
- 批准号:
10663022 - 财政年份:2023
- 资助金额:
$ 37.15万 - 项目类别:
TFH-TARGETING GENETIC ADJUVANTS TO PROMOTE DURABLE ANTI-INFLUENZA STEM ANTIBODIES IN OLDER ADULTS.
靶向 TFH 的基因佐剂可促进老年人产生持久的抗流感干抗体。
- 批准号:
10933286 - 财政年份:2023
- 资助金额:
$ 37.15万 - 项目类别: